Bionano Genomics (BNGO) Receivables - Other (2021 - 2025)

Bionano Genomics (BNGO) has 5 years of Receivables - Other data on file, last reported at $12000.0 in Q4 2025.

• For the quarter ending Q4 2025, Receivables - Other fell 45.45% year-over-year to $12000.0; the trailing twelve-month figure through Dec 2025 stood at $12000.0 (down 45.45% YoY), and the FY2025 full-year result was $200000.0, down 33.33% from the prior year.
• Receivables - Other retreated to $12000.0 in Q4 2025, from $22000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $474000.0 in Q4 2022 to a low of $12000.0 in Q4 2025.
• A 5-year average of $247400.0 and a median of $342000.0 in 2023 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other gained 22.48% in 2022 and slumped 93.57% in 2024, its largest moves.
• Tracing BNGO's Receivables - Other over 5 years: stood at $387000.0 in 2021, then gained by 22.48% to $474000.0 in 2022, then dropped by 27.85% to $342000.0 in 2023, then tumbled by 93.57% to $22000.0 in 2024, then slumped by 45.45% to $12000.0 in 2025.
• Business Quant data shows BNGO's Receivables - Other at $12000.0 in Q4 2025, $22000.0 in Q4 2024, and $342000.0 in Q4 2023.